News GLP-1s from Novo, Lilly 'should be first-line in obesity' European doctors have said GLP-1 drugs are so effective in obesity that they should be the first choice drug treatment in almost all cases.
Views & Analysis Simplicity, practicality and accessibility – primary care ph... New clinical practice guidelines emerge at such a speed that it is all but impossible for primary care physicians to keep up with medical developments. This has concerning implicat
News United's PAH drug clears phase 3 trial, setting up filings United Therapeutics will file ralinepag as a treatment for pulmonary arterial hypertension later this year, but can it compete in a crowded market?
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.